Certainly, I think there's a large push right now to look at the development of a foot-and-mouth disease vaccine bank, specifically one that is domestic to Canada and not just the one that is shared across North America. There are priorities around that and, I think, some work. However, to a certain extent, we're also dealing with it case by case. Foot-and-mouth disease is one, but African swine fever is another story entirely. We don't have vaccine candidates for that, right now. Avian flu is also handled differently.
Looking at a more comprehensive approach—not necessarily just a hazard-by-hazard approach in terms of specific diseases—and at the issue of the availability of vaccines and drugs cohesively, as an industry and as a nation, would be beneficial to every disease we might possibly be looking at in the future.